Physician profile
David Young
NPI 1285954321
$8,360.32
in general payments reported to CMS, 2019-2025
37 companies · $1,090 in 2025
The $1,090 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $304 · 2020: $116 · 2021: $197 · 2022: $4,629 · 2023: $980 · 2024: $1,044 · 2025: $1,090.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,114.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,978.14 | 2022 | |
| Glaxosmithkline, LLC. | $701.33 | 2019-2025 | Nucala, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals Lp | $504.80 | 2019-2024 | Fasenra, Tezspire, Breztri |
| Genzyme Corporation | $349.72 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $324.46 | 2019-2025 | Dupixent |
| Insmed, INC. | $245.67 | 2020-2025 | Arikayce, Brinsupri |
| Mylan Specialty L.P. | $235.21 | 2019-2024 | Yupelri |
| Inari Medical, INC. | $198.06 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $194.63 | 2021-2022 | |
| Harmony Biosciences LLC | $162.86 | 2022-2025 | |
| Pulmonx Corporation | $148.14 | 2023-2025 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Axsome Therapeutics, INC. | $133.18 | 2023-2025 | Sunosi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $132.62 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $127.05 | 2020-2025 | Zerbaxa, Recarbrio, Keytruda |
| United Therapeutics Corporation | $107.32 | 2022-2025 | Tyvaso, Tyvaso |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.